4.4 Review

Overview of rationale and clinical trials with signal transduction inhibitors in lung cancer

Journal

SEMINARS IN ONCOLOGY
Volume 29, Issue 1, Pages 15-26

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/sonc.2002.31524

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available